Tech Company Inital Public Offerings
TetraPhase Pharmaceuticals IPO
TetraPhase Pharmaceuticals, based in Watertown, had an IPO event on 3/20/2013.
Transaction Overview
Company Name
Announced On
3/20/2013
Transaction Type
IPO
Amount
$74,900,000
Proceeds Purpose
Proceeds purposes are on file with company statements at the SEC.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
480 Arsenal St. 110
Watertown, MA 02472
USA
Watertown, MA 02472
USA
Phone
Website
Email Address
Overview
Tetraphase Pharmaceuticals is focused on the discovery and development of new tetracycline antibiotics to treat drug resistant bacterial infections.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Guy Macdonald
Chief Medical Officer
Larry Tsai
Chief Operating Officer
Larry Edwards
Chief Scientific Officer
Jacques Dumas
VP - Finance
Christopher Watt
VP - General Counsel
Maria Stahl
Browse more venture capital transactions:
Prev: 3/20/2013: ScoreBig venture capital transaction
Next: 3/20/2013: CloudMine venture capital transaction
Share this article
Where The Data Comes From
We report on funding rounds that are announced publicly. VC investment data records reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs